Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03230565

Continuous Infusions vs Scheduled Bolus Infusions

The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Stanford University

Stanford, California, 94305, United States

Location status: Recruiting

Location contact

Archana Verma

CONTACT

Jean Louis-Horn, MD

PRINCIPAL_INVESTIGATOR

About this study

Regional anesthetic techniques are an integral part to many anesthetic approaches, providing both intraoperative and postoperative anesthesia and analgesia. Regional anesthesia peripheral nerve blocks have been shown to reduce postoperative pain and improve measures such as opioid requirements and readiness for discharge. By using a catheter technique for continuous peripheral nerve blocks, analgesia can be extended well into post-operative days 2 and 3, further extending these benefits. Historically these catheters have implemented a continuous dosing regimen of local anesthetic, but increasingly there is evidence of improved analgesic outcomes without adverse effects by using a scheduled bolus dosing regimen. Many institutions have implemented this new protocol for catheter dosing. The beneficial effect of scheduled bolus dosing has not been studied in all blocks and all surgical procedures.

The study will consist of three independent arms, each designed to evaluate a different nerve block site: interscalene, adductor canal, and infraclavicular. A total of 60 patients will be enrolled in each arm.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients presenting for nerve block catheters for post-operative analgesia
  • ASA physical status I, II, or III.

Exclusion criteria

  • Pregnancy
  • Incarceration
  • Age <18
  • BMI >35
  • Pre-operative opioid use >30 mg morphine equivalents per day
  • Inability to communicate with investigators by telephone
  • Pre-existing neuropathy of the operative extremity.

Treatment and study plan

Ropivacaine

Drug

Patient will be given a continuous infusion of local anesthetic.

Other names: Continuous infusion

Primary outcomes

  1. Post-surgical pain

    Time frame: Post-operative day 0, 1, and 2

    Pain scores will be collected using a Numeric Rating Scale (NRS) from 0-10, where 0 is the lowest and 10 is the highest pain level.

Secondary outcomes

  1. Opioid consumption

    Time frame: Post-operative day 0, 1, and 2

    The amount of opioid analgesics (converted to total morphine milligram equivalents) taken by patients will be recorded.

  2. Local anesthetic use

    Time frame: Post-operative day 1 and 2

    The amount of supplemental local anesthetic boluses self-administered by patients will be recorded (in mL).

  3. Quality of recovery

    Time frame: Post-operative day 1 and 2

    Quality of recovery will be assessed using a Quality of Recovery (QoR-15) questionnaire. The QoR15 scores range from 0 to 150, where 0 is poor recovery and 150 is excellent recovery.

  4. Evidence of diaphragmatic paralysis

    Time frame: Post-operative day 1 and 2

    Ability to breathe will be assessed as a part of QoR-15 questionnaire on 11-point scale, where 0 is never being able to breathe easily and 10 is always being able to breathe easily.

  5. Patient satisfaction

    Time frame: Post-operative day 1 and 2

    Patients will be asked to assess their satisfaction with pain management (Yes/No).

Study contacts

Contact information is provided by the study sponsor or research team.

Aaron J Deng, BS

CONTACT

[email protected]

408-914-5494

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Official study title

A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion

Important dates

Study start
2018
Primary completion
2026
Study completion
2026
First posted
Jul 26, 2017
Registry last updated
Dec 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.